Oncotarget. 2017 Mar 21. doi: 10.18632/oncotarget.16409. [Epub ahead of print]
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Kim HS1, Lee H2, Shin SJ3, Beom SH1, Jung M1, Bae S2, Lee EY2, Park KH4, Choi YY5, Son T5, Kim HI5, Cheong JH5, Hyung WJ5, Park JC6, Shin SK6, Lee SK6, Lee YC6, Koom WS7, Lim JS8, Chung HC1,4, Noh SH5, Rha SY1,4, Kim H3, Paik S2.
gastric cancer; immunohistochemistry; matched therapy; molecular subtypes; next-generation sequencing
Free full text